Bone Biologics Corporation (BBLGW) Net margin 2016–2020
Bone Biologics Corporation (BBLGW) net profit margin by fiscal year — reported net income divided by reported revenue.
-0.2%FY2020 · since FY2016: -2.4% → -0.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -0.2% | +0.1 pp |
| FY2019 | -0.3% | — |
| FY2016 | -2.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLGW financial trends
BBLGW RevenueBBLGW Net incomeBBLGW Gross profitBBLGW Gross marginBBLGW Operating incomeBBLGW Operating marginBBLGW Operating cash flowBBLGW Free cash flowBBLGW Capital expendituresBBLGW Return on equityBBLGW Stock buybacksBBLGW Dividends paidBBLGW Total assetsBBLGW Total liabilitiesBBLGW Shareholders’ equityBBLGW overview →